BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14071706)

  • 1. SOME PATHOGENETIC MECHANISMS OF WHITE THROMBUS FORMATION: AGGLUTINATION AND SELF-DESTRUCTION OF THE PLATELET.
    RODMAN NF; MASON RG; BRINKHOUS KM
    Fed Proc; 1963; 22():1356-65. PubMed ID: 14071706
    [No Abstract]   [Full Text] [Related]  

  • 2. PLATELETS AND ATHEROSCLEROSIS.
    MUSTARD JF; MURPHY EA; ROWSELL HC; DOWNIE HG
    J Atheroscler Res; 1964; 4():1-28. PubMed ID: 14112229
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF SULFHYDRYL INHIBITORS ON PLATELET AGGLUTINABILITY.
    ROBINSON CW; MASON RG; WAGNER RH
    Proc Soc Exp Biol Med; 1963; 113():857-61. PubMed ID: 14073124
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of fibrinolytic products on platelets: an electron microscope study.
    Barnhart MI; Riddle JM
    Thromb Diath Haemorrh Suppl; 1967; 26():87-105. PubMed ID: 4965105
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet-platelet interaction: relationship to hemostasis and thrombosis.
    Rodman NF; Mason RG
    Fed Proc; 1967; 26(1):95-105. PubMed ID: 6018930
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro assay of platelet adhesiveness with washed and tanned human red cells.
    Zbinden G; Tomlin S
    Thromb Diath Haemorrh; 1968 Dec; 20(3):384-96. PubMed ID: 4974756
    [No Abstract]   [Full Text] [Related]  

  • 7. THE PLATELET IN HEMOSTASIS.
    SPAET TH
    Ann N Y Acad Sci; 1964 Jul; 115():31-42. PubMed ID: 14192838
    [No Abstract]   [Full Text] [Related]  

  • 8. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
    Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
    Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
    Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet acid phosphatase availability.
    Kubisz P; Pinkhas J; Caen JP
    Isr J Med Sci; 1970; 6(4):494-7. PubMed ID: 4990606
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of thrombia on the distribution of adenine nucleotides in washed thrombocytes of rats].
    Zivković RV; Zivković MS; Srinivasan S
    Acta Med Iugosl; 1970; 24(1):27-33. PubMed ID: 4989454
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of platelet aggregation and of its inhibition by adenosine derivatives.
    Born GV
    Fed Proc; 1967; 26(1):115-7. PubMed ID: 6018914
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.
    Dubois C; Panicot-Dubois L; Gainor JF; Furie BC; Furie B
    J Clin Invest; 2007 Apr; 117(4):953-60. PubMed ID: 17380206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology, pathogenesis and frequency of thromboembolic disease.
    Bergentz SE
    Acta Chir Scand Suppl; 1968; 387():11-4. PubMed ID: 4183693
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinically relevant concentrations of dopamine do not amplify agonist-induced human platelet Ca2+ mobilization or GP IIb IIIa activation and do not accelerate acute coronary thrombosis in dogs.
    Sill JC; Bertha B; Berger I; Southorn V; Folts J
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):246-52. PubMed ID: 19247190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAPID ADHESIVE PLATELET COUNT IN WHOLE BLOOD.
    EASTHAM RD
    J Clin Pathol; 1964 Jan; 17(1):45-6. PubMed ID: 14100001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
    Wang X; Hsu MY; Steinbacher TE; Monticello TM; Schumacher WA
    Thromb Res; 2007; 119(5):593-600. PubMed ID: 16797058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombogenicity of some biomedical materials: platelet-interface reactions.
    Mason RG; Scarborough DE; Saba SR; Brinkhous KM
    J Biomed Mater Res; 1969 Dec; 3(4):615-44. PubMed ID: 5360015
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
    Cauwenberghs S; Feijge MA; Theunissen E; Heemskerk JW; van Pampus EC; Curvers J
    Br J Haematol; 2007 Feb; 136(3):480-90. PubMed ID: 17176266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.